Logo image of SEQUA.BR

SEQUANA MEDICAL NV (SEQUA.BR) Stock Fundamental Analysis

EBR:SEQUA - Euronext Brussels - BE0974340722 - Common Stock - Currency: EUR

1.061  +0.04 (+3.82%)

Fundamental Rating

1

SEQUA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. SEQUA has a bad profitability rating. Also its financial health evaluation is rather negative. SEQUA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SEQUA had negative earnings in the past year.
SEQUA had a negative operating cash flow in the past year.
SEQUA had negative earnings in each of the past 5 years.
In the past 5 years SEQUA always reported negative operating cash flow.
SEQUA.BR Yearly Net Income VS EBIT VS OCF VS FCFSEQUA.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

SEQUA has a Return On Assets of -449.06%. This is amonst the worse of the industry: SEQUA underperforms 94.92% of its industry peers.
Industry RankSector Rank
ROA -449.06%
ROE N/A
ROIC N/A
ROA(3y)-296.55%
ROA(5y)-236.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEQUA.BR Yearly ROA, ROE, ROICSEQUA.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

SEQUA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEQUA.BR Yearly Profit, Operating, Gross MarginsSEQUA.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

0

2. Health

2.1 Basic Checks

SEQUA does not have a ROIC to compare to the WACC, probably because it is not profitable.
SEQUA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SEQUA has more shares outstanding
The debt/assets ratio for SEQUA is higher compared to a year ago.
SEQUA.BR Yearly Shares OutstandingSEQUA.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SEQUA.BR Yearly Total Debt VS Total AssetsSEQUA.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

SEQUA has an Altman-Z score of -46.46. This is a bad value and indicates that SEQUA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -46.46, SEQUA is doing worse than 91.53% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -46.46
ROIC/WACCN/A
WACC5.59%
SEQUA.BR Yearly LT Debt VS Equity VS FCFSEQUA.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M -40M

2.3 Liquidity

SEQUA has a Current Ratio of 0.12. This is a bad value and indicates that SEQUA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.12, SEQUA is doing worse than 93.22% of the companies in the same industry.
SEQUA has a Quick Ratio of 0.12. This is a bad value and indicates that SEQUA is not financially healthy enough and could expect problems in meeting its short term obligations.
SEQUA has a Quick ratio of 0.08. This is amonst the worse of the industry: SEQUA underperforms 91.53% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.08
SEQUA.BR Yearly Current Assets VS Current LiabilitesSEQUA.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

SEQUA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.40%.
Looking at the last year, SEQUA shows a very negative growth in Revenue. The Revenue has decreased by -85.19% in the last year.
Measured over the past years, SEQUA shows a very negative growth in Revenue. The Revenue has been decreasing by -35.84% on average per year.
EPS 1Y (TTM)1.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.68%
Revenue 1Y (TTM)-85.19%
Revenue growth 3Y-34.21%
Revenue growth 5Y-35.84%
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 14.29% on average over the next years. This is quite good.
The Revenue is expected to grow by 666.97% on average over the next years. This is a very strong growth
EPS Next Y47.62%
EPS Next 2Y14.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year733.33%
Revenue Next 2Y666.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SEQUA.BR Yearly Revenue VS EstimatesSEQUA.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M
SEQUA.BR Yearly EPS VS EstimatesSEQUA.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SEQUA. In the last year negative earnings were reported.
Also next year SEQUA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEQUA.BR Price Earnings VS Forward Price EarningsSEQUA.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEQUA.BR Per share dataSEQUA.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

SEQUA's earnings are expected to grow with 14.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.29%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SEQUA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEQUANA MEDICAL NV

EBR:SEQUA (6/20/2025, 11:39:23 AM)

1.061

+0.04 (+3.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-03 2025-04-03/amc
Earnings (Next)N/A N/A
Inst Owners49.23%
Inst Owner ChangeN/A
Ins Owners5.87%
Ins Owner ChangeN/A
Market Cap58.00M
Analysts83.64
Price Target4.05 (281.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25%
EPS NY rev (1m)0%
EPS NY rev (3m)15.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-92.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 549.81
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.2
EYN/A
EPS(NY)-0.26
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0
BVpS-0.81
TBVpS-0.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -449.06%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-296.55%
ROA(5y)-236.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.46%
Cap/Sales 90.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.08
Altman-Z -46.46
F-Score2
WACC5.59%
ROIC/WACCN/A
Cap/Depr(3y)113.39%
Cap/Depr(5y)92.99%
Cap/Sales(3y)87.76%
Cap/Sales(5y)73.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.68%
EPS Next Y47.62%
EPS Next 2Y14.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-85.19%
Revenue growth 3Y-34.21%
Revenue growth 5Y-35.84%
Sales Q2Q%-100%
Revenue Next Year733.33%
Revenue Next 2Y666.97%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-13.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.3%
OCF growth 3YN/A
OCF growth 5YN/A